Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
blog-list-cover
Recent blog posts
MMP26 Biologics Sequence Review Report 2026: Matrix metalloproteinase-26 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
MMP26 Biologics Sequence Review Report 2026: Matrix metalloproteinase-26 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of MMP26 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
MMP25 Biologics Sequence Review Report 2026: Matrix metalloproteinase-25 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
MMP25 Biologics Sequence Review Report 2026: Matrix metalloproteinase-25 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of MMP25 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
MMP23B Biologics Sequence Review Report 2026: Matrix metalloproteinase-23 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
MMP23B Biologics Sequence Review Report 2026: Matrix metalloproteinase-23 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of MMP23B protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
MMP21 Biologics Sequence Review Report 2026: Matrix metalloproteinase-21 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
MMP21 Biologics Sequence Review Report 2026: Matrix metalloproteinase-21 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of MMP21 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
MMP20 Biologics Sequence Review Report 2026: Matrix metalloproteinase-20 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
MMP20 Biologics Sequence Review Report 2026: Matrix metalloproteinase-20 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of MMP20 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
MMP19 Biologics Sequence Review Report 2026: Matrix metalloproteinase-19 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
MMP19 Biologics Sequence Review Report 2026: Matrix metalloproteinase-19 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of MMP19 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
MMP14 Biologics Sequence Review Report 2026: Matrix metalloproteinase-14 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
MMP14 Biologics Sequence Review Report 2026: Matrix metalloproteinase-14 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of MMP14 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
LRPAP1 Biologics Sequence Review Report 2026: Alpha-2-macroglobulin receptor-associated protein Similarity and Patent-Risk Signals
8 min read
LRPAP1 Biologics Sequence Review Report 2026: Alpha-2-macroglobulin receptor-associated protein Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of LRPAP1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
LRP5L Biologics Sequence Review Report 2026: Low-density lipoprotein receptor-related protein 5-like protein Similarity and Patent-Risk Signals
8 min read
LRP5L Biologics Sequence Review Report 2026: Low-density lipoprotein receptor-related protein 5-like protein Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of LRP5L protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
LRP11 Biologics Sequence Review Report 2026: Low-density lipoprotein receptor-related protein 11 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
LRP11 Biologics Sequence Review Report 2026: Low-density lipoprotein receptor-related protein 11 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of LRP11 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
KLRG2 Biologics Sequence Review Report 2026: Killer cell lectin-like receptor subfamily G member 2 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
KLRG2 Biologics Sequence Review Report 2026: Killer cell lectin-like receptor subfamily G member 2 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of KLRG2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
KLRG1 Biologics Sequence Review Report 2026: Killer cell lectin-like receptor subfamily G member 1 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
KLRG1 Biologics Sequence Review Report 2026: Killer cell lectin-like receptor subfamily G member 1 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of KLRG1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →